Does Rallies show NERV 10-K and 10-Q filings?

Rallies organizes NERV SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.

Is NERV research on Rallies investment advice?

No. Rallies provides research, data, and educational context for NERV. It does not provide personalized investment advice.

NERV (Minerva Neurosciences, Inc) Stock Analysis - SEC Filings

Minerva Neurosciences, Inc (NERV) is a publicly traded Healthcare sector company. As of May 21, 2026, NERV trades at $4.67 with a market cap of $220.83M and a P/E ratio of -0.14. NERV moved +15.71% today. Year to date, NERV is +21.20%; over the trailing twelve months it is +264.49%. Its 52-week range spans $1.15 to $12.46. Analyst consensus is buy with an average price target of $10.50. Rallies surfaces NERV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find NERV SEC filings?

Rallies organizes NERV SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

NERV Key Metrics

Key financial metrics for NERV
Metric	Value
Price	$4.67
Market Cap	$220.83M
P/E Ratio	-0.14
EPS	$-34.67
Dividend Yield	0.00%
52-Week High	$12.46
52-Week Low	$1.15
Volume	40
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-293.42M
Gross Margin	0.00%

Latest NERV News

Minerva Appoints Jim O’Connor as CBO Ahead of Phase 3 Rolupe-ridone Trial — Apr 2, 2026
Minerva Neurosciences Screens First Patient in 380-Patient Phase 3 Trial with Topline Data Due 2H 2027 — Mar 31, 2026
Minerva Neurosciences Finds No Safety Concerns in Roluperidone-Olanzapine Trial, Phase 3 Underway — Mar 25, 2026

Recent NERV Insider Trades

Luthringer Remy sold 3.64K (~$13.69K) on May 2, 2023.
Luthringer Remy sold 23.75K (~$91.45K) on May 1, 2023.
Race Geoff sold 22.08K (~$85.02K) on May 1, 2023.

NERV Analyst Consensus

2 analysts cover NERV: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.50.

Common questions about NERV

Where can I find NERV SEC filings?: Rallies organizes NERV SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show NERV 10-K and 10-Q filings?: Rallies organizes NERV SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is NERV research on Rallies investment advice?: No. Rallies provides research, data, and educational context for NERV. It does not provide personalized investment advice.